Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

538
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
538
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

667
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
667
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

786
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homeostatic changes of trace elements in silica toxicity in rat model: the beneficial role of resveratrol.

International journal of environmental health research·2025
Same author

Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples.

BMC cancer·2025
Same author

Utilizing an In-silico Approach to Pinpoint Potential Biomarkers for Enhanced Early Detection of Colorectal Cancer.

Cancer informatics·2024
Same author

Homeostatic changes of trace elements in diazinon toxicity in rat model: The beneficial role of resveratrol.

Toxicology reports·2024
Same author

Circular RNAs in tuberculosis: From mechanism of action to potential diagnostic biomarker.

Microbial pathogenesis·2023
Same author

Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation.

Computers in biology and medicine·2023

Related Experiment Video

Updated: Mar 6, 2026

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

11.1K

AdipoRon may be benefit for atherosclerosis prevention.

Maryam Esfahani1, Nooshin Shabab2, Massoud Saidijam3

  • 1Department of Biochemistry and Nutrition, Hamadan University of Medical Sciences, Hamadān, Iran.

Iranian Journal of Basic Medical Sciences
|March 16, 2017
PubMed
Summary

AdipoRon, a synthetic molecule, may prevent atherosclerosis by activating adiponectin receptors (AdipoR1/AdipoR2). This molecule shows potential for treating coronary artery disease and improving metabolic health.

Keywords:
AdipoRonAdiponectinAdiponectin receptorsAtherosclerosisCardiovascular diseases

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.6K
Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
02:55

Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention

Published on: October 6, 2023

2.1K

Related Experiment Videos

Last Updated: Mar 6, 2026

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

11.1K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.6K
Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
02:55

Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention

Published on: October 6, 2023

2.1K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Atherosclerosis, a major cause of coronary artery disease, necessitates effective prevention and treatment strategies.
  • Adiponectin, an abundant adipokine, possesses insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties.
  • Dysfunctional adiponectin signaling via its receptors (AdipoR1, AdipoR2) may contribute to atherosclerosis development.

Discussion:

  • AdipoRon, an orally active synthetic molecule, binds and activates AdipoR1 and AdipoR2.
  • AdipoRon activates key signaling pathways: AdipoR1-AMPK-PGC-1α and AdipoR2-PPAR-α.
  • Previous studies suggest AdipoRon exhibits insulin sensitivity, anti-apoptotic, and anti-oxidative effects.

Key Insights:

  • This study hypothesizes that AdipoRon exerts anti-atherosclerotic effects by suppressing atherosclerosis progression.
  • AdipoRon's activation of adiponectin receptors and downstream pathways supports its potential therapeutic role.
  • The molecule's demonstrated effects on insulin sensitivity and oxidative stress are relevant to cardiovascular health.

Outlook:

  • Confirmation of AdipoRon's benefits could lead to its use in patients at risk of atherosclerotic development.
  • Further research into AdipoRon's precise mechanisms in atherosclerosis is warranted.
  • AdipoRon represents a potential novel therapeutic agent for managing atherosclerosis and related cardiovascular conditions.